200 related articles for article (PubMed ID: 18808525)
1. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.
Yamamoto T; Kato Y; Shibata N; Sawada T; Osawa M; Kobayashi M
Int J Exp Pathol; 2008 Oct; 89(5):332-41. PubMed ID: 18808525
[TBL] [Abstract][Full Text] [Related]
2. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
[TBL] [Abstract][Full Text] [Related]
3. Co-localization of fukutin and alpha-dystroglycan in the mouse central nervous system.
Ohtsuka-Tsurumi E; Saito Y; Yamamoto T; Voit T; Kobayashi M; Osawa M
Brain Res Dev Brain Res; 2004 Sep; 152(2):121-7. PubMed ID: 15351499
[TBL] [Abstract][Full Text] [Related]
4. Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains.
Saito Y; Yamamoto T; Mizuguchi M; Kobayashi M; Saito K; Ohno K; Osawa M
Brain Res; 2006 Feb; 1075(1):223-8. PubMed ID: 16466646
[TBL] [Abstract][Full Text] [Related]
5. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
[TBL] [Abstract][Full Text] [Related]
6. Functions of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in neuromuscular system and other somatic organs.
Yamamoto T; Shibata N; Saito Y; Osawa M; Kobayashi M
Cent Nerv Syst Agents Med Chem; 2010 Jun; 10(2):169-79. PubMed ID: 20518731
[TBL] [Abstract][Full Text] [Related]
7. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
[TBL] [Abstract][Full Text] [Related]
8. Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T; Kawaguchi M; Sakayori N; Muramatsu F; Morikawa S; Kato Y; Shibata N; Kobayashi M
Neurosci Res; 2006 Dec; 56(4):391-9. PubMed ID: 17005282
[TBL] [Abstract][Full Text] [Related]
9. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of fukutin and fukutin-related protein in muscle cells.
Matsumoto H; Noguchi S; Sugie K; Ogawa M; Murayama K; Hayashi YK; Nishino I
J Biochem; 2004 Jun; 135(6):709-12. PubMed ID: 15213246
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of fukutin in an astrocytoma cell line.
Yamamoto T; Kato Y; Hiroi A; Shibata N; Osawa M; Kobayashi M
Int J Exp Pathol; 2012 Feb; 93(1):46-55. PubMed ID: 22264285
[TBL] [Abstract][Full Text] [Related]
13. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
[TBL] [Abstract][Full Text] [Related]
14. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
15. Roles of fukutin, the gene responsible for fukuyama-type congenital muscular dystrophy, in neurons: possible involvement in synaptic function and neuronal migration.
Hiroi A; Yamamoto T; Shibata N; Osawa M; Kobayashi M
Acta Histochem Cytochem; 2011 Apr; 44(2):91-101. PubMed ID: 21614170
[TBL] [Abstract][Full Text] [Related]
16. Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression.
Ohtsuka Y; Kanagawa M; Yu CC; Ito C; Chiyo T; Kobayashi K; Okada T; Takeda S; Toda T
Sci Rep; 2015 Feb; 5():8316. PubMed ID: 25661440
[TBL] [Abstract][Full Text] [Related]
17. [Hint and luck for identification of a gene for Fukuyama muscular dystrophy, fukutin].
Toda T
Rinsho Shinkeigaku; 2007 Nov; 47(11):743-8. PubMed ID: 18210789
[TBL] [Abstract][Full Text] [Related]
18. Basement membrane fragility underlies embryonic lethality in fukutin-null mice.
Kurahashi H; Taniguchi M; Meno C; Taniguchi Y; Takeda S; Horie M; Otani H; Toda T
Neurobiol Dis; 2005; 19(1-2):208-17. PubMed ID: 15837576
[TBL] [Abstract][Full Text] [Related]
19. Expression of genes related to muscular dystrophy with lissencephaly.
Yamamoto T; Kato Y; Karita M; Kawaguchi M; Shibata N; Kobayashi M
Pediatr Neurol; 2004 Sep; 31(3):183-90. PubMed ID: 15351017
[TBL] [Abstract][Full Text] [Related]
20. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
